Payers and clinical professionals TDIs in Poland and the Czech Republic

Working with global research agency SODA completed qualitative study on Multiple Sclerosis in Poland and the Czech Republic. The aim of the research was to better understand how MS is managed and treated and identify the clinical and public policy factors that restrict patient access to MS treatments in each market. We conducted a series of interviews with former payers and payer advisors, and various clinical professionals who are experienced in treating multiple sclerosis, assessing MS treatments, reimbursement or setting guidelines for MS.

Comments are closed.